• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources

About Us

An estimated 2.4 million people in the U.S. are living with Hepatitis C infection.

Making data on the viral hepatitis epidemic widely available, easily accessible, and locally relevant to inform public health decision making.

HepVu is an online platform that visualizes data and disseminates insights on the viral hepatitis epidemic across the U.S. HepVu’s mission is to make data widely available, easily accessible, and locally relevant to inform public health decision-making. HepVu is a Powered By AIDSVu project presented by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc.

Limited data is one of the most critical gaps in our national response to viral hepatitis. Though deaths associated with Hepatitis C continue to surpass the total combined number of deaths from 60 other reportable infectious diseases – including HIV, pneumococcal disease, and tuberculosis – the public health surveillance system for Hepatitis C is not as robust or extensive as it is for other infectious diseases like HIV. This makes it challenging to understand the scope of the Hepatitis C epidemic in the U.S. and develop tailored strategies to improve access to screening, treatment, and prevention services.

In January 2021, the U.S. Department of Health and Human Services (HHS) released its Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025. The plan outlines objectives and strategies to aid stakeholders—researchers, policy makers, health care providers, advocacy groups, and patients—in working together to eliminate viral hepatitis as a public health threat in the U.S.

View Report

To help address this challenge, HepVu visualizes data related to the Hepatitis C epidemic in the U.S., including:

Standardized, state-level estimates of people living with Hepatitis C infection and Hepatitis C-related mortality, stratified by sex, age, and race. HepVu also has more granular Hepatitis C-related mortality data and maps at the county-level.

Learn More

HepVu serves as a central hub of information about the impact of the opioid epidemic on Hepatitis C and maps county-level rates of opioid prescriptions and rates of overdose mortality, as well as state-level rates of opioid prescriptions, percent of pain reliever misuse, and rates of overdose mortality.

Learn More

The state-level Hepatitis C prevalence estimates on HepVu were derived from the Emory University CAMP project with researchers from the University of Albany and support from CDC. Findings were published in the peer-reviewed Journal of the American Medical Association (JAMA) Network Open in the paper, “Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2013 – 2016.”

Building on this methodology, the state-level stratifications of Hepatitis C prevalence by sex, age, and race were developed by researchers at Georgia State University, Emory University, CDC, and the University at Albany and published in Hepatology Communications in the paper, “Hepatitis C virus prevalence in 50 U.S. states and D.C. by sex, birth cohort, and race: 2013–2016.”

The county-level Hepatitis C-related mortality data were published in Hall et al.’s article in Hepatology titled “County-Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005-2017,” and then released on HepVu in February 2021. Findings were developed by researchers at Emory University with researchers from Georgia State University, the University at Albany, and CDC.

HepVu’s county-level opioid prescription and overdose mortality rates data were originally calculated in a study published in Drug and Alcohol Dependence.

HepVu and AIDSVu receive ongoing support and guidance from three groups consisting of key stakeholders and experts:

  • Advisory Committee
  • Technical Advisory Group
  • Prevention and Treatment Advisory Committee.

HepVu is also advised by working groups convened on specific topics, including viral hepatitis and opioids.

The development of HepVu was guided by the following group of viral hepatitis experts:

Principal Scientist Patrick Sullivan, DVM, PhD
Professor, Department of Epidemiology, Rollins School of Public Health, Emory University

HepVu Co-Chair Ronald Valdiserri, MD, MPH
Professor, Department of Epidemiology, Rollins School of Public Health, Emory University, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services

HepVu Project Director Heather Bradley, PhD
Associate Professor, Department of Epidemiology, Emory University Rollins School of Public Health

Richard Garfein, Ph.D., MPH, Professor in the Division of Global Public Health, Department of Medicine at UCSD

Timothy M. Block, Professor, Co‐Founder and President, Hepatitis B Foundation and Baruch S. Blumberg Institute

Dawn Fishbein, MD, Scientific Director, Viral Hepatitis Research, MedStar Health Research Institute

Jim Galbraith, MD, Associate Professor, UAB Emergency Medicine Department

Charles Howell, MD, Chair of Medicine, Howard University Hospital

Gregorio Millett, MPH, Vice President and Director, Public Policy, amfAR

Shauna Onofrey, MPH, Epidemiologist, Massachusetts Department of Health

Alexandra Shirreffs, Viral Hepatitis Prevention Coordinator, Philadelphia Health Department

John Ward, MD, Director, Program for Viral Hepatitis Elimination, The Task Force for Global Health, Former Director of the Division of Viral Hepatitis at CDC

Powered By AIDSVu projects use the existing AIDSVu.org infrastructure to help visualize complex data from other projects to inform public health.

Advisory Committee

Gregg Alton, Former Chief Patient Officer, Gilead Sciences, Inc

James Curran, MD, Dean, Rollins School of Public Health, Emory University

Guillermo Chacon, President, Latino Commission on AIDS

Chari Cohen, DrPH, MPH, President of Hepatitis B Foundation

Demetre Daskalakis, MD, MPH, Director of the Division of HIV/AIDS Prevention, CDC

Carlos del Rio, MD, Hubert Professor and Chair of the Department of Global Health at the Rollins School of Public Health and Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, co-Director of the Emory Center for AIDS Research (CFAR)

Carl Dieffenbach, PhD, Director, Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health

Judith Feinberg, MD, Professor, Behavioral Medicine & Psychiatry, WVU School of Medicine

Evelyn Foust, MPH, CPM, Branch Head, Communicable Diseases, North Carolina Division of Public Health

Kevin Frost, Chief Executive Officer, amfAR

Christy Ross, Director of Health and Wellbeing, NAACP

Jennifer Kates, PhD, Vice President and Director of Global Health & HIV Policy, Kaiser Family Foundation

Stephen Lee, MD, Executive Director, NASTAD

Marsha Martin, DSW, Prior Director, Urban Coalition for HIV/AIDS Prevention Services

Henry Masur, MD, Chief, Critical Care Medicine Department, NIH Clinical Center

Jesse Milan, Jr., JD, President and CEO, AIDS United

Gregorio Millett, MPH, Vice President and Director, Public Policy, amFAR

Michael Mugavero, MD, MHSc, Associate Professor, Division of Infectious Diseases, University of Alabama at Birmingham, School of Medicine

Stacey Trooskin, MD, PhD, MPH, Chief Medical Officer of Philadelphia FIGHT Community Health Centers and Clinical Assistant Professor of Medicine at University of Pennsylvania

Michael Ninburg, Executive Director Emeritus, Hepatitis Education Project

Rekha Ramesh, Executive Director, Head of Public Policy, Gilead Sciences

Ron Valdiserri, MD, MPH, Professor, Department of Epidemiology, Rollins School of Public Health, Emory University, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services

Su Wang, MD, MPH, Medical Director for Center for Asian Health & Viral Hepatitis Programs at Saint Barnabas Medical Center and President of World Hepatitis Alliance

Carolyn Wester, MD, MPH, Director, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC

Technical Advisory

Kathleen Brady, MD, PhD, Director of HIV Epidemiology for the Philadelphia Department of Public Health

Natalie Cramer, Senior Director, Prevention, Health Care Access, and Policy, National Alliance of State & Territorial AIDS Directors

Stacy Cohen, MPH, Chief – Evaluation, Analysis, and Dissemination Branch, Division of Policy and Data, HIV/AIDS Bureau, HRSA

Virginia Takeuchi, Supervising Epidemiologist, HIV Surveillance, Division of HIV/STD Programs, Los Angeles County Department of Public Health

Jeff Lauritsen, HIV/AIDS Epidemiologist, City of Chicago Department of Public Health

Eve Mokotoff, Managing Director, HIV Counts, LLC

Anna Satcher-Johnson, Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, HIV Incidence and Case Surveillance Branch

Debbie Wendell, PhD, MPH, Data Management & Analysis Program Manager, STD/HIV Program, Louisiana Department of Health and Hospitals, Office of Public Health

Lorene Maddox, Analysis Manager, HIV/AIDS Section, Bureau of Communicable Diseases Florida Department of Health

Prevention and Treatment Advisory Committee

Jacob Dougherty, HIV Prevention Coordinator, Wisconsin Department of Health Services, HIV Program

Pascale Wortley, MD, MPH, HIV Epidemiology Section Chief at the Georgia Department of Public Health

Margaret Vaaler, PhD, Epidemiology and Supplemental Projects Group Manager, TB/HIV/STD Epidemiology and Surveillance Branch Texas Department of State Services

4 Ways to HepVu

Explore Maps

Explore the interactive map, customize your view, and easily print for presentations, grant applications, or other materials

Learn More

View Local Statistics

View local statistics for your state, and download high-impact data visualizations for your work

Learn More

Download Data

Download the data sets that inform HepVu’s visualizations for your own research and analysis

Learn More

Share Infographics

Download and share our educational infographics

Learn More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.